# NCT06361927 (NCT06361927)

> A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06361927
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Conditions: NSCLC
- Interventions: SSGJ-707
- Enrollment: 120
- Primary outcome: ORR

## Commentary we found

- X threads: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct06361927